Search Results - "Babarskienė, Marija Rūta"

Impact of electrical shock waveform and paddle positions on efficacy of direct current cardioversion for atrial fibrillation by Stanaitiene, Giedre, Babarskiene, Rūta Marija

“…Direct-current electrical cardioversion is the main method for the conversion of atrial fibrillation. Its success depends on many factors. In several studies,…”
Get full text

Anterior-posterior versus anterior-lateral electrode position for biphasic cardioversion of atrial fibrillation by Brazdzionyte, Julija, Babarskiene, Rūta Marija, Stanaitiene, Giedre

“…The aim of the study was to assess if the anterior-posterior electrode position for the conversion of atrial fibrillation using biphasic waveform shocks is…”
Get more information

Impact of duration and treatment of arterial hypertension on health-related quality of life by Raskeliene, Vilma, Babarskiene, Marija Rūta, Macijauskiene, Jūrate, Seskevicius, Arvydas

“…Arterial hypertension (AH) is one of the most important risk factors for development of ischemic heart disease; thus, control of AH and effective treatment are…”
Get full text

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial by Forette, Françoise, Seux, Marie-Laure, Staessen, Jan A, Thijs, Lutgarde, Birkenhäger, Willem H, Babarskiene, Marija-Ruta, Babeanu, Speranta, Bossini, Alfredo, Gil-Extremera, Blas, Girerd, Xavier, Laks, Tovio, Lilov, Emil, Moisseyev, Valentine, Tuomilehto, Jaakko, Vanhanen, Hannu, Webster, John, Yodfat, Yair, Fagard, Robert

“…Systolic hypertension increases the risk of dementia in elderly people. The vascular dementia project, set up in the framework of the double-blind…”
Get full text

The risk of cardiovascular death following the first acute ischaemic syndrome: experience in Kaunas between 1997 and 2001 by Zaliünas, Remigijus, Babarskiene, Marija Rüta, Luksiene, Dalia, Slapikiene, Birute, Vencloviene, Jone, Milvidaite, Irena, Slapikas, Rimvydas

“…The aim of our study was twofold: initially to investigate the effects of the informative value of the variables of the acute period on the risk of…”
Get full text

Lethal outcomes in patients with symptomatic heart failure developed after Q-wave myocardial infarction by Zaliūnas, Remigijus, Babarskiene, Marija Rūta, Kavoliūniene, Ausra, Slapikiene, Birute, Luksiene, Dalia, Slapikas, Rimvydas, Vencloviene, Jone

“…The article analyses clinical characteristics and mortality of patients with symptomatic chronic heart failure following Q-wave myocardial infarction. During…”
Get more information

Prognostication of long-term outcomes for patients with ischemic heart disease by Umbrasienė, Jelena, Jankauskienė, Edita, Kupstytė, Nora, Babarskienė, Marija Rūta, Venclovienė, Jonė, Gustienė, Olivija

“…Cardiovascular disease, including coronary heart disease (CHD), is the leading cause of death among elderly adults across many European countries. In 2005, the…”
Get full text

Informative value of clinical markers for the risk of cardiovascular death in postinfarction chronic heart failure by Zaliunas, Remigijus, Babarskiene, Marija-Ruta, Slapikas, Rimvydas, Slapikiene, Birute, Luksiene, Dalia, Vencloviene, Jone, Janenaite, Jurate

“…Symptomatic chronic heart failure (CHF) in patients with previous myocardial infarction results in a high risk of death.The aim of the study was to determine…”
Get full text

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study by Forette, Françoise, Seux, Marie-Laure, Staessen, Jan A, Thijs, Lutgarde, Babarskiene, Marija-Ruta, Babeanu, Speranta, Bossini, Alfredo, Fagard, Robert, Gil-Extremera, Blas, Laks, Tovio, Kobalava, Zhanna, Sarti, Cinzia, Tuomilehto, Jaakko, Vanhanen, Hannu, Webster, John, Yodfat, Yair, Birkenhäger, Willem H

“…After the double-blind, placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial ended in February 1997, randomized patients were offered active…”
Get more information

Associations between acute heart failure and cardiovascular outcomes by Milvidaitė, Irena, Lukšienė, Dalia, Slapikienė, Birutė, Babarskienė, Marija Rūta, Slapikas, Rimvydas, Venclovienė, Jonė

“…The aim of the study was to determine associations of acute coronary syndrome and acute heart failure with mortality from cardiovascular causes during…”
Get full text

A possible association between space weather conditions and the risk of acute coronary syndrome in patients with diabetes and the metabolic syndrome by Vencloviene, Jone, Babarskiene, Ruta Marija, Kiznys, Deivydas

“…Hyperglycemia negatively affects cardiovascular variables that are also adversely affected by increased geomagnetic activity. It is likely that geomagnetic…”
Get full text

Admission hyperglycemia and abnormal glucose tolerance at discharge in patients with acute myocardial infarction and no previous history of diabetes mellitus by Milvidaite, Irena, Slapikas, Rimvydas, Statkeviciene, Audrone, Babarskiene, Marija Rūta, Luksiene, Dalia, Slapikiene, Birute

“…The objective of this study was to determine frequency of admission hyperglycemia and abnormal glucose tolerance at discharge in patients with acute myocardial…”
Get full text

Prognostication of late left ventricular systolic dysfunction in patients with acute coronary syndrome during the acute period by Babarskiene, Marija Rūta, Vencloviene, Jone, Luksiene, Dalia, Slapikiene, Birute, Milvidaite, Irena, Slapikas, Rimvydas, Janenaite, Jūrate

“…The aim of the study was to create the model of the combination of clinical and echocardiographic determinants during the acute period of acute coronary…”
Get full text

The short-term associations of weather and air pollution with emergency ambulance calls for paroxysmal atrial fibrillation by Vencloviene, Jone, Babarskiene, Ruta Marija, Dobozinskas, Paulius, Dedele, Audrius, Lopatiene, Kristina, Ragaisyte, Nijole

“…A circadian variation in the cardiovascular parameters has been detected. It is plausible that the influence of the environment varies during different periods…”
Get full text

Secondary prevention of ischemic heart disease: pharmacological treatment after myocardial infarction according to follow-up protocol by Milvidaite, Irena, Luksiene, Dalia, Slapikiene, Birute, Babarskiene, Marija Rūta, Liukaitis, Valdas, Maciulaitis, Romas, Kadusevicius, Edmundas, Pilviniene, Rugile

“…The aim of this work was to assess the quality of pharmacological treatment in patients within one year after acute myocardial infarction. We performed a…”
Get full text

Treatment of patients with ischemic heart disease and diabetes by Zaliūnas, Remigijus, Babarskiene, Marija Rūta, Brazdzionyte, Julija

“…Around one third of patients with myocardial infarction are diabetic. More vigorous control of hyperglycemia, hyperlipidemia, and hypertension is likely to be…”
Get more information

Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes by Slapikas, Rimvydas, Luksiene, Dalia, Slapikiene, Birute, Babarskiene, Marija Rūta, Grybauskiene, Regina, Linoniene, Leonarda

“…Low-density lipoprotein (LDL) heterogeneity is now well recognized as an important factor reflecting differences in lipoprotein composition, size, metabolism…”
Get more information

Ischemic heart disease mortality risk in patients with diabetes mellitus by Zaliūnas, Remigijus, Babarskiene, Marija Rūta, Luksiene, Dalia, Slapikiene, Birute, Milvidaite, Irena, Vencloviene, Jone

“…The significance of clinical characteristics during acute phase of coronary syndrome for hospital prognosis is well established. However their prognostic…”
Get more information

Cardiac events and 5-year survival after acute coronary syndromes by Zaliūnas, Remigijus, Babarskiene, Marija Rūta, Luksiene, Dalia, Vencloviene, Jone, Slapikiene, Birute, Milvidaite, Irena, Statkeviciene, Eugenija Audrone, Linoniene, Vita

“…To evaluate the incidence of cardiac events and survival in patients with first acute coronary syndromes during 5-year period. Data on 732 patients admitted…”
Get more information

Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly by Staessen, J A, Fagard, R, Thijs, L, Celis, H, Birkenhäger, W H, Bulpitt, C J, de Leeuw, P W, Fletcher, A E, Babarskiene, M R, Forette, F, Kocemba, J, Laks, T, Leonetti, G, Nachev, C, Petrie, J C, Tuomilehto, J, Vanhanen, H, Webster, J, Yodfat, Y, Zanchetti, A

“…In 1989, the European Working Party on High Blood Pressure in the Elderly started the double-blind, placebo-controlled, Systolic Hypertension in Europe Trial…”
Get more information